Kazaoka Y - Search Results

1

Activated cytotoxic T-lymphocyte immunotherapy is effective for advanced oral and maxillofacial cancers.

Ohtani T, Yamada Y, Furuhashi A, Ohmura Y, Nakamura S, Kato H, Yoshikawa K, Kazaoka Y. Ohtani T, et al. Among authors: kazaoka y. Int J Oncol. 2014 Nov;45(5):2051-7. doi: 10.3892/ijo.2014.2599. Epub 2014 Aug 14. Int J Oncol. 2014. PMID: 25120101

2

Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy.

Ohmura Y, Yoshikawa K, Saga S, Ueda R, Kazaoka Y, Yamada S. Ohmura Y, et al. Among authors: kazaoka y. Oncol Rep. 2008 May;19(5):1265-70. Oncol Rep. 2008. PMID: 18425386

3

Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma.

Kondo Y, Yoshikawa K, Omura Y, Shinohara A, Kazaoka Y, Sano J, Mizuno Y, Yokoi T, Yamada S. Kondo Y, et al. Among authors: kazaoka y. Oncol Rep. 2011 May;25(5):1227-33. doi: 10.3892/or.2011.1216. Epub 2011 Mar 10. Oncol Rep. 2011. PMID: 21399882

4

Effective three-dimensional evaluation analysis of upper airway form during oral appliance therapy in patients with obstructive sleep apnoea.

Furuhashi A, Yamada S, Shiomi T, Sasanabe R, Aoki Y, Yamada Y, Kazaoka Y. Furuhashi A, et al. Among authors: kazaoka y. J Oral Rehabil. 2013 Aug;40(8):582-9. doi: 10.1111/joor.12059. Epub 2013 May 21. J Oral Rehabil. 2013. PMID: 23692649

5

Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.

Nakaoka T, Ota A, Ono T, Karnan S, Konishi H, Furuhashi A, Ohmura Y, Yamada Y, Hosokawa Y, Kazaoka Y. Nakaoka T, et al. Among authors: kazaoka y. Cell Oncol (Dordr). 2014 Apr;37(2):119-29. doi: 10.1007/s13402-014-0167-7. Epub 2014 Mar 6. Cell Oncol (Dordr). 2014. PMID: 24599717

6

Plumbagin suppresses tumor cell growth in oral squamous cell carcinoma cell lines.

Ono T, Ota A, Ito K, Nakaoka T, Karnan S, Konishi H, Furuhashi A, Hayashi T, Yamada Y, Hosokawa Y, Kazaoka Y. Ono T, et al. Among authors: kazaoka y. Oral Dis. 2015 May;21(4):501-11. doi: 10.1111/odi.12310. Epub 2015 Jan 29. Oral Dis. 2015. PMID: 25580997

7

Inhibition of Nox1 induces apoptosis by attenuating the AKT signaling pathway in oral squamous cell carcinoma cell lines.

Ito K, Ota A, Ono T, Nakaoka T, Wahiduzzaman M, Karnan S, Konishi H, Furuhashi A, Hayashi T, Yamada Y, Hosokawa Y, Kazaoka Y. Ito K, et al. Among authors: kazaoka y. Oncol Rep. 2016 Nov;36(5):2991-2998. doi: 10.3892/or.2016.5068. Epub 2016 Sep 5. Oncol Rep. 2016. PMID: 27600098

8

Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study.

Nishio-Nagai M, Suzuki S, Yoshikawa K, Ueda R, Kazaoka Y. Nishio-Nagai M, et al. Among authors: kazaoka y. Int J Oncol. 2017 Nov;51(5):1471-1481. doi: 10.3892/ijo.2017.4142. Epub 2017 Oct 2. Int J Oncol. 2017. PMID: 29048671 Free PMC article.

9

Metronidazole-induced encephalopathy caused by hyperbaric oxygen therapy in a patient with mandibular osteomyelitis.

Yamamoto Y, Asai N, Furuhashi A, Ono T, Yamagishi Y, Mikamo H, Kazaoka Y. Yamamoto Y, et al. Among authors: kazaoka y. J Infect Chemother. 2019 Dec;25(12):1057-1059. doi: 10.1016/j.jiac.2019.05.022. Epub 2019 Jun 14. J Infect Chemother. 2019. PMID: 31204183

10

Treatment outcome of oral appliance in patients with REM-related obstructive sleep apnea.

Nishio Y, Hoshino T, Murotani K, Furuhashi A, Baku M, Sasanabe R, Kazaoka Y, Shiomi T. Nishio Y, et al. Among authors: kazaoka y. Sleep Breath. 2020 Dec;24(4):1339-1347. doi: 10.1007/s11325-019-01966-5. Epub 2019 Nov 25. Sleep Breath. 2020. PMID: 31768931 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters